165 results on '"Sumimoto, Hidetoshi"'
Search Results
2. Oncogenic epidermal growth factor receptor signal-induced histone deacetylation suppresses chemokine gene expression in human lung adenocarcinoma
3. Biphasic prognostic significance of PD-L1 expression status in patients with early- and locally advanced-stage non-small cell lung cancer
4. Detection of neoantigen-reactive T cell clones based on the clonal expansion using next-generation sequencing of T cell receptor β complementarity-determining region 3
5. Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer
6. Sox9 regulates the luminal stem/progenitor cell properties of salivary glands
7. Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors.
8. Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors
9. Roles of Signaling Pathways in Cancer Cells and Immune Cells in Generation of Immunosuppressive Tumor-Associated Microenvironments
10. Common Marmoset as a New Preclinical Animal Model for Human Gene Therapy of Hematological Disorders
11. O2-5-3 - Identification of candidate lung cancer neoantignes by next generation sequencing towards precision medicine
12. Tumor growth suppression by adenovirus-mediated introduction of a cell growth suppressing gene tob in a pancreatic cancer model
13. Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells
14. The mechanisms of cancer immunoescape and development of overcoming strategies
15. Factors Associated with Cancer-Related Pain Requiring High-Dose Opioid Use in Palliative Cancer Patients
16. Immunological detection of altered signaling molecules involved in melanoma development
17. Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference
18. Cancer-induced immunosuppressive cascades and their reversal by molecular-targeted therapy
19. The RNA Silencing Technology Applied by Lentiviral Vectors in Oncology
20. Biphasic prognostic significance of PD-L1 expression status in patients with early- and locally advanced-stage non-small cell lung cancer
21. Abstract 1019: EGFR signal induces T cell non-inflamed tumor microenvironment (TME) through suppression of chemokine production from human EGFRmt lung adenocarcinoma
22. Simultaneous suppression of MITF and BRAFV600E enhanced inhibition of melanoma cell proliferation
23. 60. INHIBITION OF PROLIFERATION AND INVASION OF MELANOMA CELLS BY INACTIVATION OF MITF WITH LENTIVIRAL SHRNA
24. 1. IMMUNOTHERAPY AND GENE THERAPY USING VIRAL VECTORS
25. Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi
26. Possible involvement of allogeneic antigens recognised by donor-derived CD4+ cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy
27. A Case of Oxycodone-related Respiratory Depression Induced by Tumor Lysis Syndrome
28. Rapid and efficient generation of lentivirally gene-modified dendritic cells from DC progenitors with bone marrow stromal cells
29. RAS Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung Cancers
30. Identification of candidate lung cancer neoantignes by next generation sequencing towards precision medicine
31. Abstract 3708: RAS-MAPK signal is required for enhanced PD-L1 expression in human lung cancers
32. RAS–Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung Cancers
33. RAS-MAPK signaling is required for the enhanced PD-L1 expression in human lung cancers
34. O2-11-3 - RAS-MAPK signaling is required for the enhanced PD-L1 expression in human lung cancers
35. This title is unavailable for guests, please login to see more information.
36. This title is unavailable for guests, please login to see more information.
37. Improvement of Cancer Immunotherapy by Combining Molecular Targeted Therapy
38. Immune Suppression and Resistance Mediated by Constitutive Activation of Wnt/β-Catenin Signaling in Human Melanoma Cells
39. Transplantation of side population cells restores the function of damaged exocrine glands through clusterin
40. Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells
41. Enhanced Cancer Immunotherapy Using STAT3-Depleted Dendritic Cells with High Th1-Inducing Ability and Resistance to Cancer Cell-Derived Inhibitory Factors
42. Blast Phase of Chronic Myeloid Leukemia Presenting Lymphoid Phenotype with a Chronic Phase of Extremely Short Duration
43. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice
44. Lentiviral vector-mediated RNAi and its use for cancer research
45. The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells
46. 422. Enhancement of Human Monocyte-Derived Dendritic Cell Functions by Adenovirus- Mediated RNA Interference of STAT-3
47. The Role of the Activated MAPK Pathway through the Oncogenic BRAFV600E-Mutation in the Immune Escaping Mechanism of Melanoma
48. 963. MITF as a Potential Molecular Target for Gene Therapy for Human Melanoma; a Synergistic Inhibitory Effect of Inactivation of Both MITF and BRAFV600E on Melanoma Growth
49. Use of RNA interference technology for cancer specific gene silencing
50. Identification of human tumor antigens and its implications for diagnosis and treatment of cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.